BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Context Therapeutics Reports Second Quarter 2023 Operating and Financial Results

  Context Therapeutics Inc., a biopharmaceutical company advancing medicines for solid tumors, announced its financial results for the second quarter ended June 30, 2023, and reported on recent and upcoming business highlights.

  August 9, 2023

   · 

  6 min read
• Business

  Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results

  Accuray Incorporated reported financial results for the fourth quarter and fiscal 2023, ended June 30, 2023.

  August 9, 2023

   · 

  18 min read
• Business

  Dr. Steven Barnard Appointed Chief Technology Officer

  Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced Dr. Steven Barnard, Illumina’s Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer, effective immediately.

  August 9, 2023

   · 

  3 min read
• Business

  INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

  INVO Bioscience, Inc. will report financial results for its second quarter 2023, for the period ended June 30, 2023, after the market close on Monday, August 14, 2023.

  August 9, 2023

   · 

  3 min read
• Business

  Edesa Biotech Reports Fiscal Third Quarter 2023 Results

  Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, reported financial results for the three and nine months ended June 30, 2023 and provided an update on its business.

  August 9, 2023

   · 

  11 min read
• Business

  Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update

  Catalyst Pharmaceuticals, Inc. reported financial results for the second quarter of 2023 and provided a corporate update.

  August 9, 2023

   · 

  12 min read
• Business

  Matinas BioPharma Reports Second Quarter 2023 Financial Results and Provides a Business Update

  Matinas BioPharma, a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal platform delivery technology, reports financial results for the three and six months ended June 30, 2023 and provides a business update.

  August 9, 2023

   · 

  13 min read
• Business

  Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates

  Assembly Biosciences, Inc., a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, reported financial results and recent updates for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  7 min read
• Business

  TELA Bio Reports Second Quarter 2023 Financial Results

  TELA Bio, Inc. reported financial results for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  8 min read
• Business

  Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

  Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, reported financial results and provided a corporate update for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  10 min read